| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2027 ( Subtotal = -$1 ) |
| | 2027 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | F32DA067053 | Individualized Modeling of Neurodevelopmental Network Dynamics Predicting Cannabis Risk and Escalation in Adolescence | 000 | 1 | NIH | 10/23/2026 | $0 |
| | 2027 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135899 | Leveraging Machine Learning Approaches to Understand Mechanisms of Exposure Therapy in Real-World Settings | 000 | 3 | NIH | 10/13/2026 | $0 |
| | 2027 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01AG098047 | Computing and deploying normative models for early detection of cerebrovascular deviations predictive of Alzheimer's Disease onset | 000 | 1 | NIH | 10/26/2026 | $0 |
| | 2027 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21HD123315 | Gut Microbiome Mechanisms of Multisensory Sensitivity in Primary Dysmenorrhea | 000 | 1 | NIH | 10/23/2026 | $0 |
| | 2027 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01HD120801 | Decoding Dysmenorrhea: Longitudinal Modeling of Pelvic Pain Phenotypes in Adolescents and Young Adults | 000 | 1 | NIH | 10/23/2026 | $0 |
| | 2027 | 2025 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD111352 | Transgenerational Impact of Childhood Maltreatment on Structural/Functional Properties of Visual Cortex | 000 | 6 | NIH | 10/27/2026 | $0 |
| | 2027 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA050780 | Increasing Women's Engagement in Medication Treatment for Opioid Use Disorder through Digital Intervention | 000 | 5 | NIH | 10/16/2026 | $0 |
| | 2027 | 2024 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA017846 | Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders | 000 | 15 | NIH | 10/21/2026 | $0 |
| | 2027 | 2023 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG061100 | A Randomized Controlled Trial of Electroconvulsive Therapy plus Usual Care versus Simulated-ECT plus Usual Care for the Acute Management of Severe Agitation in Alzheimer's Dementia (ECT-AD) | 000 | 5 | NIH | 10/16/2026 | -$1 |
|
| Issue Date FY: 2026 ( Subtotal = $31,088,200 ) (Continued on the next page) |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH138861 | Observing brain lactate dynamics during a working memory task in first episode and chronic schizophrenia | 000 | 2 | NIH | 2/5/2026 | $205,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134885 | 3/5- Biomarkers to Enhance Early Schizophrenia Treatment (BEEST) | 000 | 3 | NIH | 7/29/2026 | $413,754 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH137459 | A Multilevel Characterization of Sensory Cortical Disinhibition in Post-Traumatic Intrusions | 000 | 3 | NIH | 7/31/2026 | $179,117 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS129188 | Human iPSC-Based Personalized Cell Therapy of PD | 000 | 4 | NIH | 5/5/2026 | $689,100 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01NS127391 | Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands | 000 | 4 | NIH | 5/1/2026 | $432,440 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH129374 | Parent interpretation bias as a key mechanism of intergenerational transmission of anxiety | 000 | 4 | NIH | 5/19/2026 | $743,794 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH134074 | Imaging the Functional State of the D2high Receptor in drug induced dopamine supersensitivity in schizophrenia | 000 | 3 | NIH | 1/28/2026 | $666,559 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH137075 | Personalized Quality of Life Measurement | 000 | 3 | NIH | 4/1/2026 | $549,472 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 001 | 5 | NIH | 8/23/2026 | $0 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH126000 | Empirical validation of a cerebellar-cortical hallucination circuit | 000 | 5 | NIH | 12/10/2025 | $572,264 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AA030585 | Insula-amygdala circuits in alcohol abuse | 000 | 4 | NIH | 7/29/2026 | $516,261 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K00HD112293 | Elucidating interactions among early life adversity, sleep architecture, and immune function | 000 | 6 | NIH | 1/8/2026 | $103,215 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH135093 | Molecular Mechanisms of Aging in Schizophrenia: Implications of Bioenergetic Metabolism and Redox Biology | 000 | 3 | NIH | 12/12/2025 | $888,999 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23MH132900 | Shared and differential vulnerabilities of stress and reward processing in psychosis-risk syndromes or early-stage depression | 000 | 3 | NIH | 12/3/2025 | $178,416 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA058315 | Impact of prescription stimulants on the drug overdose epidemic | 000 | 4 | NIH | 3/23/2026 | $714,786 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K08MH130802 | Understanding Foxp2-Mediated Molecular Signaling in Fear Learning | 000 | 4 | NIH | 6/25/2026 | $193,993 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH139697 | Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression | 000 | 2 | NIH | 5/26/2026 | $680,594 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32MH125786 | Training to Enhance Alignment of Psychiatry and Neuroscience | 001 | 5 | NIH | 4/17/2026 | $3,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH129828 | Multimodal characterization of affective visual processing in the early aftermath of trauma | 000 | 4 | NIH | 12/1/2025 | $179,707 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA047575 | Neural and Behavioral Consequences of Chronic THC Exposure During Adolescence | 000 | 7 | NIH | 3/30/2026 | $1,235,789 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | P50MH115846 | Laboratory for Early Psychosis Research (LEAP) | 000 | 8 | NIH | 8/17/2026 | $1,951,130 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH117292 | Site 3/3, Understanding PTSD through Postmortem Targeted Brain Multiomics | 000 | 7 | NIH | 2/25/2026 | $902,371 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24AA025977 | Mentoring in Patient-Oriented Neuroscience Research | 000 | 10 | NIH | 8/12/2026 | $162,796 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH137441 | Tracking the dynamic trajectory of behavioral, physiological, and neurobiological stress responses in female adolescents at high and low familial risk for depression. | 000 | 2 | NIH | 4/27/2026 | $705,959 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | T32DA015036 | Training in Drug Abuse and Brain Imaging | 000 | 25 | NIH | 5/22/2026 | $148,319 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K24DA061976 | Mentoring in Patient-Oriented Research on Substance Use Disorders | 000 | 2 | NIH | 1/28/2026 | $208,575 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01DA065290 | Neurobiological Correlates of Susceptibility, Resilience, and Recovery to Substance Abuse in Participants with Childhood Maltreatment | 000 | 1 | NIH | 9/3/2026 | $981,978 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01AG098047 | Computing and deploying normative models for early detection of cerebrovascular deviations predictive of Alzheimer's Disease onset | 000 | 1 | NIH | 9/11/2026 | $126,900 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R21MH141189 | Synaptic function programs in neuron-astrocyte co-cultures from human post-mortem brain tissue | 000 | 1 | NIH | 8/28/2026 | $463,229 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K08MH143068 | Examining the role of BDNF in the synaptic neuron-astrocyte program underlying genetic risk for schizophrenia | 000 | 1 | NIH | 9/10/2026 | $194,400 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH143749 | Synaptic Mechanisms of Intermittent Theta Burst Stimulation for Major Depressive Disorder | 000 | 1 | NIH | 8/31/2026 | $771,937 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG080636 | ApoE, lipid and immune mechanisms of human neurons and glia | 001 | 2 | NIH | 3/9/2026 | $76,143 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG080636 | ApoE, lipid and immune mechanisms of human neurons and glia | 000 | 2 | NIH | 12/17/2025 | $685,289 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01AG096687 | Data-driven identification of imaging-based and genetic-based hemodynamic biomarkers of Alzheimer's Disease | 000 | 1 | NIH | 9/4/2026 | $687,568 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH146063 | Pilot Hybrid Effectiveness-Implementation Trial of a Scalable Intervention Targeting Postpartum Intrusive Thoughts | 000 | 1 | NIH | 8/10/2026 | $410,000 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | R01MH145639 | Trauma Recovery via EEG and Actigraphy Tracking (TREAT): Biomarkers of Written Exposure Therapy in PTSD | 000 | 1 | NIH | 8/20/2026 | $819,998 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | RF1MH136052 | MDMA Mechanisms of Prohedonic Efficacy: A Reverse Translational Approach | 000 | 2 | NIH | 4/24/2026 | $2,876,123 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K01MH138555 | Neurocognitive mechanisms of the negative retrieval bias in depression | 000 | 1 | NIH | 6/23/2026 | $179,096 |
| | 2026 | 2026 | THE MCLEAN HOSPITAL CORPORATION | 115 MILL ST | BELMONT | MA | 02478-1064 | MIDDLESEX | USA | K23DA063863 | Identifying individual clinical and environmental predictors of buprenorphine response to inform treatment for opioid use disorder | 000 | 1 | NIH | 5/25/2026 | $194,206 |
|
